Bronchopulmonary dysplasia (BPD) is a unique injury syndrome caused by prolonged injury
and repair imposed on an immature and developing lung. The decreased septation and …

Bronchopulmonary dysplasia (BPD), the chronic lung disease associated with preterm birth,
results from the disruption of normal pulmonary vascular and alveolar growth. Though BPD …

BACKGROUND: Inhaled nitric oxide (iNO) therapy is an off-label medication in infants< 34
weeks' gestational age. In 2011, the National Institutes of Health released a statement …

The objective of this study is to review the candidate gene and genome-wide association
studies relevant to bronchopulmonary dysplasia, and to discuss the emerging …

Introduction: As more infants are surviving at younger gestational ages, bronchopulmonary
dysplasia (BPD) remains as a frequent neonatal complication occurring after preterm birth …

The available evidence does not support the routine use of inhaled nitric oxide (iNO) in the
care of premature infants. We present a case series of 22 preterm infants born after …

In the current issue of the journal, Ellsworth1 et al report a small but significant increase
(from 5.0% to 6.2%) in the off-label use of inhaled nitric oxide (iNO) between 2009 and 2013 …

Introduction: The key feature of the newborn is its fast age-dependent maturation, resulting
in extensive variability in pharmacokinetics and-dynamics, further aggravated by newly …

Ergänzende Therapien bei Neugeborenen mit schwerem respiratorischen Versagen
monary interstitial emphysema and other forms of neonatal air leaks [10]. Pulmonary air …